341 related articles for article (PubMed ID: 14612513)
21. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
22. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.
Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A
Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509
[TBL] [Abstract][Full Text] [Related]
23. G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation.
Hong JH; Gatti RA; Huo YK; Chiang CS; McBride WH
Radiat Res; 1994 Oct; 140(1):17-23. PubMed ID: 7938450
[TBL] [Abstract][Full Text] [Related]
24. Combination of genistein with ionizing radiation on androgen-independent prostate cancer cells.
Yan SX; Ejima Y; Sasaki R; Zheng SS; Demizu Y; Soejima T; Sugimura K
Asian J Androl; 2004 Dec; 6(4):285-90. PubMed ID: 15546018
[TBL] [Abstract][Full Text] [Related]
25. Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation.
Winter RN; Rhee JG; Kyprianou N
Anticancer Res; 2004; 24(3a):1377-86. PubMed ID: 15274298
[TBL] [Abstract][Full Text] [Related]
26. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
27. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.
Zhao H; Spitz MR; Tomlinson GE; Zhang H; Minna JD; Wu X
Cancer Res; 2001 Nov; 61(21):7819-24. PubMed ID: 11691798
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
Palayoor ST; Bump EA; Teicher BA; Coleman CN
Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
[TBL] [Abstract][Full Text] [Related]
29. Effect of p53 overexpression on radiation sensitivity of human colon cancer cells.
Zellars RC; Naida JD; Davis MA; Lawrence TS
Radiat Oncol Investig; 1997; 5(2):43-9. PubMed ID: 9303056
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
31. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.
Meyer KM; Hess SM; Tlsty TD; Leadon SA
Oncogene; 1999 Oct; 18(42):5795-805. PubMed ID: 10523860
[TBL] [Abstract][Full Text] [Related]
32. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
33. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
[TBL] [Abstract][Full Text] [Related]
34. Wild-type p53 reduces radiation hypermutability in p53-mutated human lymphoblast cells.
Zhang Q; Liu Y; Zhou J; Chen W; Zhang Y; Liber HL
Mutagenesis; 2007 Sep; 22(5):329-34. PubMed ID: 17567629
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation.
Fan Z; Chakravarty P; Alfieri A; Pandita TK; Vikram B; Guha C
Cancer Gene Ther; 2000 Oct; 7(10):1307-14. PubMed ID: 11059687
[TBL] [Abstract][Full Text] [Related]
36. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
[TBL] [Abstract][Full Text] [Related]
37. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
38. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity.
Fernet M; Mégnin-Chanet F; Hall J; Favaudon V
DNA Repair (Amst); 2010 Jan; 9(1):48-57. PubMed ID: 19926348
[TBL] [Abstract][Full Text] [Related]
39. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.
Ohnishi K; Scuric Z; Schiestl RH; Okamoto N; Takahashi A; Ohnishi T
Radiat Res; 2006 Sep; 166(3):454-62. PubMed ID: 16972754
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells.
Bataller M; Portugal J
Arch Biochem Biophys; 2005 May; 437(2):151-8. PubMed ID: 15850555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
